CompletedPhase 4

Evaluation of Efficacy and Hypothalamus-pituitary-adrenal Axis Suppression Due to Corticosteroids Intrabursal Injection

Italy44 participantsStarted 2012-03

Plain-language summary

The purpose of this study is to compare the efficacy and effects on the hypothalamus-pituitary-adrenal axis of a single intrabursal injection of two different types of corticosteroids (methylprednisolone and triamcinolone) in patients with calcific shoulder tendinopathy.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * painful rotator cuff calcific tendonitis demonstrated by ultrasounds Exclusion Criteria: * pregnancy * use of corticosteroids in the previous 2 months * systemic chronic inflammatory or allergic diseases * allergy to methylprednisolone or triamcinolone * diabetes * glaucoma * coagulopathies or current treatment with antiaggregants or anticoagulants * septic arthritis or infections * calcific enthesopathy

What they're measuring

Functional Improvement Measured According to Percentage Change in Constant Score

Timeframe: 180 days after treatment

Trial details

NCT IDNCT01652495

SponsorIstituto Ortopedico Rizzoli

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-05

Results submitted2014-03-22

View on ClinicalTrials.gov More Tendinopathy trials